|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1306 NOK | +4.48% |
|
-5.91% | -53.02% |
BerGenBio ASA reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was NOK 0.389 million compared to NOK 0.774 million a year ago. Net loss was NOK 77.19 million compared to NOK 68.77 million a year ago.
Basic loss per share from continuing operations was NOK 0.87 compared to NOK 0.78 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -53.02% | 47.81M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -14.15% | 21.84B | |
| -1.05% | 21.96B | |
| -5.29% | 19.21B | |
| -38.29% | 17.71B | |
| -4.16% | 18.08B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
BERGENBIO ASA 
